These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17374335)

  • 41. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.
    Di Monta G; Caracò C; Benedetto L; La Padula S; Marone U; Tornesello ML; Buonaguro FM; Simeone E; Ascierto PA; Mozzillo N
    Eur J Surg Oncol; 2014 Jan; 40(1):61-6. PubMed ID: 24075826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alitretinoin.
    Am J Health Syst Pharm; 2002 Feb; 59(4):333-4. PubMed ID: 11885395
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of classical type Kaposi's sarcoma with paclitaxel.
    Chao SC; Lee JY; Tsao CJ
    Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kaposi's sarcoma. An update on the results of extended field radiotherapy.
    Harwood AR
    Arch Dermatol; 1981 Dec; 117(12):775-8. PubMed ID: 7316552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
    Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
    J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of iatrogenic Kaposi's sarcoma with low-dose docetaxel therapy.
    Yamashiro A; Awazawa R; Ohira A; Hirata T; Zamami R; Miyagi T; Takahashi K
    J Dermatol; 2018 Apr; 45(4):e96-e97. PubMed ID: 29215145
    [No Abstract]   [Full Text] [Related]  

  • 48. Non-HIV Kaposi's sarcoma: a review and therapeutic perspectives.
    Akasbi Y; Awada A; Arifi S; Mellas N; El Mesbahi O
    Bull Cancer; 2012 Oct; 99(10):92-9. PubMed ID: 23017657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cutaneous Kaposi's sarcoma with pulmonary carcinomatous lymphangitis in patient with heart transplantation].
    Philit F; Mornex JF; Dureau G; Chuzel M; Euvrard S; Ecochard D; Brune J
    Rev Mal Respir; 1994; 11(4):421-3. PubMed ID: 7973044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection of herpes virus-like DNA in various forms of Kaposi's sarcoma but not in other mesenchymal tumors or inflammatory changes in skin].
    Cathomas G; McGandy CE; Terracciano LM; Itin PH; DeRosa G; Mihatsch MJ; Gudat F
    Verh Dtsch Ges Pathol; 1996; 80():318-21. PubMed ID: 9065036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Kaposi's sarcoma with bleomycin.
    Kim R; Guerrero RC; Ho R
    Cutis; 1979 Jan; 23(1):73-6. PubMed ID: 83223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.
    Meseguer-Yebra C; Cardeñoso-Álvarez ME; Bordel-Gómez MT; Fraile-Alonso MC; Pérez-Losada ME; Sánchez-Estella J
    Br J Dermatol; 2015 Sep; 173(3):860-2. PubMed ID: 25704866
    [No Abstract]   [Full Text] [Related]  

  • 54. An atypical aggressive Kaposi's sarcoma in a HIV-negative bisexual man.
    Adedayo AO; Grell GA; Boada LG; Bellot P
    West Indian Med J; 2001 Mar; 50(1):75-7. PubMed ID: 11398296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of AIDS-related Kaposi's sarcoma.
    Di Lorenzo G; Konstantinopoulos PA; Pantanowitz L; Di Trolio R; De Placido S; Dezube BJ
    Lancet Oncol; 2007 Feb; 8(2):167-76. PubMed ID: 17267331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal and cutaneous AIDS-related Kaposi's sarcoma: different activity of liposomal doxorubicin according to location of lesions.
    Hernández-Morales DE; Hernández-Zaccaro AE
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):264-6. PubMed ID: 15952971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tinnitus in a Patient Treated by Bleomycin for Kaposi's Sarcoma].
    Laschinski B; Arnault JP; Gras-Champel V
    Therapie; 2015; 70(6):539-40. PubMed ID: 26220920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kaposi's sarcoma in rheumatic diseases.
    Louthrenoo W; Kasitanon N; Mahanuphab P; Bhoopat L; Thongprasert S
    Semin Arthritis Rheum; 2003 Apr; 32(5):326-33. PubMed ID: 12701043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intralesional 3% sodium tetradecyl sulfate for treatment of cutaneous Kaposi's sarcoma.
    Kim JY; Kim JS; Kim MH; Park BC; Hong SP
    Yonsei Med J; 2015 Jan; 56(1):307-8. PubMed ID: 25510781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.